Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Disease

Monitoring Board Gives Positive Recommendation On Ocugen's Eye Disease Gene Therapy Trial

The independent Data and Safety Monitoring Board (DSMB) for Ocugen Inc's (NASDAQ:OCGN) Phase 1/2 trial of OCU400 has recommended that the study proceeds with enrolling additional subjects. The recommendation follows the review of safety data based on dosing to date. OCU400 is the Company's flagship modifier gene therapy candidate for Retinitis Pigmentosa (RP)…

Benzinga

Drug-resistant environmental mould ‘capable of infecting people’, study suggests

Researchers are calling for greater surveillance of Aspergillus fumigatus in the environment and the clinic to help understand the risk it poses.

The Independent UK

Step up COVID vigil, says Minister

A high-level review meeting organised in the context of rising cases in other States

The Hindu

From analysis to the latest developments in health,
read the most diverse news in one place.

Boston-area COVID wastewater data starts dropping: ‘I’m cautiously optimistic’

BOSTON — The closely monitored Boston-area COVID-19 wastewater data has started falling in the past few days, sending an encouraging signal to local infectious disease experts who are “cautiously optimistic” about this virus drop.

Tribune News Service

Applied Molecular's AMT-101 Shows Favorable Clinical Activity, Safety Profile In Inflammatory Bowel Disease

Applied Molecular Transport Inc (NASDAQ:AMTI) announced Phase 2 topline results from the FILLMORE monotherapy trial for AMT-101 in chronic pouchitis. Pouchitis is inflammation in the lining of a pouch created during surgery to treat ulcerative colitis or certain other diseases. The trial demonstrated that 36.4% (8/22) of patients achieved stool frequency response. Rapid…

Benzinga

FDA Plans To Convene AdComm For Ardelyx's Tenapanor For CKD Patients On Dialysis

The FDA's Office of New Drugs (OND), Center for Drug Evaluation and Research (CDER), has provided an interim response to Ardelyx Inc's (NASDAQ:ARDX) second level of appeal of the Complete Response Letter (CRL) for Xphozah. Ardelyx is seeking approval for Xphozah to control serum phosphorus in adult patients with chronic kidney disease (CKD) on…

Benzinga

Spectre of polio returns to haunt Pakistan as baby boy is left paralysed

First case in a year sparks fears of new outbreak despite success of national programme to wipe out the disease

The Guardian - UK

Read news from The Economist, FT, and more,
with one subscription

Ebola outbreak: WHO warns time isn't on our side after man, 31, dies of disease

Ebola has struck again in the Congo with the death of a 31-year-old man in Mbandaka sparking fears that the country is "playing catch up" in the latest outbreak

Daily Mirror

Investors Cheer Nkarta's First NK Cell Data With Multiple Complete Responses

Nkarta Inc (NASDAQ:NKTX) has revealed the first human results from its two lead off-the-shelf NK cell therapies, with the high-dose regimens exhibiting multiple complete responses in blood cancer patients. For NKX101, three patients achieved a complete response (CR) among five AML patients who received three doses of either 1 billion or 1.5 billion…

Benzinga

Floods create health risks: what to look out for and how to avoid them

Recently South Africa has experienced heavy rains which resulted in floods in some parts of the country. In the coastal city of Durban hundreds of people have died and families have been displaced in the aftermath. Water pipes, sewerage systems and roads have also been damaged. Public health experts, Juno…

The Conversation

Ovarian cancer is not a silent killer – recognizing its symptoms could help reduce misdiagnosis and late detection

Ovarian cancer is the most deadly of gynecologic tumors. Fewer than 40% of those diagnosed with ovarian cancer are cured, and approximately 12,810 people in the U.S. die from the disease every year.

The Conversation

Consumer Health: Understanding Creutzfeldt-Jakob disease

Creutzfeldt-Jakob disease is a rare, degenerative, fatal brain disorder. It affects about 1 person in every 1 million per year worldwide, and about 350 cases are diagnosed per year in the U.S., according to the National Institute of Neurological Disorders and Stroke.

Tribune News Service

At least one child has died due to mystery strain of ‘acute, severe’ hepatitis, WHO says

At least 169 cases of the disease reported in children in 12 countries, including the UK

The Independent UK

‘What’s this disease that keeps us making bad choices?’: Bill Hader on murder, misery and his hit comedy Barry

The actor and comedian rose to fame as ‘the impressions guy’ on Saturday Night Live. Now he’s the star of an Emmy-winning sitcom, which he also writes and directs. If only he could be less anxious about it all …

The Guardian - UK

Get all your
news in one place.

100's of premium titles.
One news app.

Reuters

Beijing shoppers throng stores as district starts mass testing

Beijing residents snapped up food and other supplies as the city's biggest district began mass COVID-19 testing of all residents on Monday, prompting fears of a Shanghai-style lockdown after dozens of cases in the capital in recent days.

Daily Mirror

Dad who thought he tripped up due to 'trapped nerve' handed 'devastating' diagnosis

Chris Thurston, 42, from Wirral, Merseyside, thought he was suffering with a trapped nerve until doctors revealed it was an early sign of a devastating incurable condition

The Times of India

World Malaria Day: Malaria claims only one life in last five years in Rajasthan

JAIPUR: Malaria was one of the most fatal diseases till 2010 in the country as more than 1,000 people were dying every year. After that mortality rate and cases have reduced significantly.

Bangkok Post

No endemic status before EOC's nod

About 15 provinces are aiming to be among the first to declare Covid-19 an endemic disease but they can't do so until they are approved by the Ministry of Public Health's Emergency Operations Centre (EOC), said Dr Suthep Petchmak, inspector-general of the ministry.

Get all your
news in one place.

100's of premium titles.
One news app.

The Hindu

‘Colorectal cancer catching up with young Indians’

Cyclothon by Hyderabad hospital raises awareness on disease

Liverpool Echo

Football mad dad's life changed forever after tripping on left foot

Chris Thurston, 42, thought his symptoms were caused by a "trapped nerve" when he started to struggle with his balance

Daily Mirror

Family heartbroken after dog 'falls victim to streets infested with large rats'

Pauline Robertson, from Page Moss, Liverpool, said her community has been overrun with rats, which she has blamed for the death of her miniature Yorkshire Terrier Coco

Daily Mirror

'Study reveals sound sleep can cut your risk of developing Alzheimer’s'

A study from the Rensselaer Polytechnic Institute, Biological Sciences, looked into how the brain cleared a harmful protein linked to Alzheimer’s disease

The Conversation

Link between Epstein-Barr virus and multiple sclerosis is a crucial discovery for people living with MS

Canada has one of the highest rates of multiple sclerosis (MS) in the world, with 250 out of every 100,000 people affected.

The Times of India

Five diseases best treated in homoeopathy

Homeopathy is a medical system developed in Germany more than 200 years ago. It’s based on the belief that minimal doses of natural substances can help stimulate the body to cure itself.

Edinburgh Live

Scotland's youngest MND patient Lucy Lintott's plans after making history with second baby

Lucy Lintott, 26, made history when she became the first person in the world to give birth twice after being diagnosed with motor neurone disease.

1 … 585 586 587 588

People

Carlos Garcia Rawlins

25 stories

Kittipong Kittikachorn

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.